_id
690dafeaccc777a4e85d0b3c
Ticker
APPB
Name
Applied Biosciences Corp
Exchange
OTCCE
Address
9701 Wilshire Boulevard, Beverly Hills, CA, United States, 90212
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.appliedbiocorp.com
Description
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
Last Close
0.0002
Volume
895
Current Price
0.0001
Change
0
Last Updated
2026-01-20T15:32:34.808Z
Image
-
Ipo Date
-
Market Cap
2200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2019-12-31
Revenue
169575
Cost Of Revenue
51343
Gross Profit
118232
Operating Expenses
1139816
Operating Income
-970241
Interest Expense
89017
Pretax Income
-1425870
Net Income
-1353390
Eps
-0.0959785988978336
Dividends Per Share
-
Shares Outstanding
22002587
Income Tax Expense
-
EBITDA
-
Operating Margin
-572.1604010025063
Total Other Income Expense Net
-366612
Cash
21268
Short Term Investments
-
Receivables
76201
Inventories
101524
Total Current Assets
213659
Property Plant Equipment
682075
Total Assets
3417927
Payables
659682
Short Term Debt
563769
Long Term Debt
-
Total Liabilities
2280392
Equity
229272
Bs_currency_symbol
USD
Depreciation
62965
Change In Working Capital
-
Cash From Operations
-52144
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-52144
Cf_currency_symbol
USD
PE
-
PB
0.0061503175267804185
ROE
-590.2988589971737
ROA
-39.59680824078455
FCF
-52144
Fcf Percent
-0.30749815715759987
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
5.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2019-12-31
Quarters > 0 > income Statement > revenue
169575
Quarters > 0 > income Statement > cost Of Revenue
51343
Quarters > 0 > income Statement > gross Profit
118232
Quarters > 0 > income Statement > operating Expenses
1139816
Quarters > 0 > income Statement > operating Income
-970241
Quarters > 0 > income Statement > interest Expense
89017
Quarters > 0 > income Statement > pretax Income
-1425870
Quarters > 0 > income Statement > net Income
-1353390
Quarters > 0 > income Statement > eps
-0.0959785988978336
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
14100956
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-572.1604010025063
Quarters > 0 > income Statement > total Other Income Expense Net
-366612
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
21268
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
76201
Quarters > 0 > balance Sheet > inventories
101524
Quarters > 0 > balance Sheet > total Current Assets
213659
Quarters > 0 > balance Sheet > property Plant Equipment
682075
Quarters > 0 > balance Sheet > total Assets
3417927
Quarters > 0 > balance Sheet > payables
659682
Quarters > 0 > balance Sheet > short Term Debt
563769
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2280392
Quarters > 0 > balance Sheet > equity
229272
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1353390
Quarters > 0 > cash Flow > depreciation
62965
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-52144
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-52144
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0959785988978336
Quarters > 0 > ratios > PB
0.0061503175267804185
Quarters > 0 > ratios > ROE
-590.2988589971737
Quarters > 0 > ratios > ROA
-39.59680824078455
Quarters > 0 > ratios > FCF
-52144
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.30749815715759987
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2019-09-30
Quarters > 1 > income Statement > revenue
244274
Quarters > 1 > income Statement > cost Of Revenue
98373
Quarters > 1 > income Statement > gross Profit
145901
Quarters > 1 > income Statement > operating Expenses
1065121
Quarters > 1 > income Statement > operating Income
-820847
Quarters > 1 > income Statement > interest Expense
38637
Quarters > 1 > income Statement > pretax Income
-855230
Quarters > 1 > income Statement > net Income
-777746
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-336.0353537421093
Quarters > 1 > income Statement > total Other Income Expense Net
4254
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
73412
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
65824
Quarters > 1 > balance Sheet > inventories
105665
Quarters > 1 > balance Sheet > total Current Assets
261905
Quarters > 1 > balance Sheet > property Plant Equipment
372551
Quarters > 1 > balance Sheet > total Assets
3484030
Quarters > 1 > balance Sheet > payables
325175
Quarters > 1 > balance Sheet > short Term Debt
491373
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1322625
Quarters > 1 > balance Sheet > equity
1180662
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-777746
Quarters > 1 > cash Flow > depreciation
39747
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-366528
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
402000
Quarters > 1 > cash Flow > net Change In Cash
35472
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-65.87372169172887
Quarters > 1 > ratios > ROA
-22.323171729290507
Quarters > 1 > ratios > FCF
-366528
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.5004789703365893
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2019-06-30
Quarters > 2 > income Statement > revenue
211457
Quarters > 2 > income Statement > cost Of Revenue
99797
Quarters > 2 > income Statement > gross Profit
111660
Quarters > 2 > income Statement > operating Expenses
693221
Quarters > 2 > income Statement > operating Income
-481764
Quarters > 2 > income Statement > interest Expense
26164
Quarters > 2 > income Statement > pretax Income
-507928
Quarters > 2 > income Statement > net Income
-423897
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-227.83071735624736
Quarters > 2 > income Statement > total Other Income Expense Net
-26164
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
37940
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
70010
Quarters > 2 > balance Sheet > inventories
115354
Quarters > 2 > balance Sheet > total Current Assets
239573
Quarters > 2 > balance Sheet > property Plant Equipment
412299
Quarters > 2 > balance Sheet > total Assets
3521303
Quarters > 2 > balance Sheet > payables
245386
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
674668
Quarters > 2 > balance Sheet > equity
1788408
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-423897
Quarters > 2 > cash Flow > depreciation
39749
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-399043
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
0
Quarters > 2 > cash Flow > cash From Financing
389939
Quarters > 2 > cash Flow > net Change In Cash
-9104
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0
Quarters > 2 > ratios > ROE
-23.702477287062013
Quarters > 2 > ratios > ROA
-12.038072270406722
Quarters > 2 > ratios > FCF
-399043
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.8871118005079046
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2019-03-31
Quarters > 3 > income Statement > revenue
234553
Quarters > 3 > income Statement > cost Of Revenue
82034
Quarters > 3 > income Statement > gross Profit
152519
Quarters > 3 > income Statement > operating Expenses
643910
Quarters > 3 > income Statement > operating Income
-409357
Quarters > 3 > income Statement > interest Expense
73995
Quarters > 3 > income Statement > pretax Income
-271963
Quarters > 3 > income Statement > net Income
-231626
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-174.52643965329798
Quarters > 3 > income Statement > total Other Income Expense Net
211389
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
47044
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
163405
Quarters > 3 > balance Sheet > inventories
78737
Quarters > 3 > balance Sheet > total Current Assets
354459
Quarters > 3 > balance Sheet > property Plant Equipment
452048
Quarters > 3 > balance Sheet > total Assets
3651448
Quarters > 3 > balance Sheet > payables
278546
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
374266
Quarters > 3 > balance Sheet > equity
2134924
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-231626
Quarters > 3 > cash Flow > depreciation
39749
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-116188
Quarters > 3 > cash Flow > capital Expenditures
1555
Quarters > 3 > cash Flow > cash From Investing
-163294
Quarters > 3 > cash Flow > cash From Financing
84955
Quarters > 3 > cash Flow > net Change In Cash
-194527
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
0
Quarters > 3 > ratios > ROE
-10.849379181647684
Quarters > 3 > ratios > ROA
-6.343401302716073
Quarters > 3 > ratios > FCF
-117743
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.5019888895047175
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2019-03-31
Annuals > 0 > income Statement > revenue
707062
Annuals > 0 > income Statement > cost Of Revenue
521774
Annuals > 0 > income Statement > gross Profit
185288
Annuals > 0 > income Statement > operating Expenses
3353361
Annuals > 0 > income Statement > operating Income
-2646299
Annuals > 0 > income Statement > interest Expense
648875
Annuals > 0 > income Statement > pretax Income
-2679022
Annuals > 0 > income Statement > net Income
-2629327
Annuals > 0 > income Statement > eps
-0.19626076071630374
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
13397110
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-1989520
Annuals > 0 > income Statement > operating Margin
-374.2668959723475
Annuals > 0 > income Statement > total Other Income Expense Net
616152
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
47044
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
163405
Annuals > 0 > balance Sheet > inventories
78737
Annuals > 0 > balance Sheet > total Current Assets
354459
Annuals > 0 > balance Sheet > property Plant Equipment
452048
Annuals > 0 > balance Sheet > total Assets
3651448
Annuals > 0 > balance Sheet > payables
278546
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
374266
Annuals > 0 > balance Sheet > equity
2134924
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-2629327
Annuals > 0 > cash Flow > depreciation
40627
Annuals > 0 > cash Flow > change In Working Capital
257273
Annuals > 0 > cash Flow > cash From Operations
-905051
Annuals > 0 > cash Flow > capital Expenditures
1555
Annuals > 0 > cash Flow > cash From Investing
-713294
Annuals > 0 > cash Flow > cash From Financing
1604455
Annuals > 0 > cash Flow > net Change In Cash
-13890
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.19626076071630374
Annuals > 0 > ratios > PB
0.0006275216354305821
Annuals > 0 > ratios > ROE
-123.15787353554506
Annuals > 0 > ratios > ROA
-72.00778978640803
Annuals > 0 > ratios > FCF
-906606
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.282215703856239
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2018-03-31
Annuals > 1 > income Statement > revenue
197554
Annuals > 1 > income Statement > cost Of Revenue
155549
Annuals > 1 > income Statement > gross Profit
42005
Annuals > 1 > income Statement > operating Expenses
1690751
Annuals > 1 > income Statement > operating Income
-1493197
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-2386864
Annuals > 1 > income Statement > net Income
-2376101
Annuals > 1 > income Statement > eps
-0.2263037389007782
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
10499610
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-1268427
Annuals > 1 > income Statement > operating Margin
-755.8424532026686
Annuals > 1 > income Statement > total Other Income Expense Net
-893667
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
60934
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
12386
Annuals > 1 > balance Sheet > inventories
29074
Annuals > 1 > balance Sheet > total Current Assets
226849
Annuals > 1 > balance Sheet > property Plant Equipment
4441
Annuals > 1 > balance Sheet > total Assets
705327
Annuals > 1 > balance Sheet > payables
21846
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
35885
Annuals > 1 > balance Sheet > equity
678469
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2376101
Annuals > 1 > cash Flow > depreciation
224770
Annuals > 1 > cash Flow > change In Working Capital
-12818
Annuals > 1 > cash Flow > cash From Operations
-673467
Annuals > 1 > cash Flow > capital Expenditures
4699
Annuals > 1 > cash Flow > cash From Investing
-173236
Annuals > 1 > cash Flow > cash From Financing
695000
Annuals > 1 > cash Flow > net Change In Cash
-151703
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.2263037389007782
Annuals > 1 > ratios > PB
0.001547544545145025
Annuals > 1 > ratios > ROE
-350.21511668182336
Annuals > 1 > ratios > ROA
-336.87934816049864
Annuals > 1 > ratios > FCF
-678166
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.4328133067414477
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2017-03-31
Annuals > 2 > income Statement > revenue
45554
Annuals > 2 > income Statement > cost Of Revenue
6391
Annuals > 2 > income Statement > gross Profit
39163
Annuals > 2 > income Statement > operating Expenses
185108
Annuals > 2 > income Statement > operating Income
-139554
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-515920
Annuals > 2 > income Statement > net Income
-517656
Annuals > 2 > income Statement > eps
-0.03394999868831816
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
15247600
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-306.3485094612987
Annuals > 2 > income Statement > total Other Income Expense Net
-376366
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
212637
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
5677
Annuals > 2 > balance Sheet > inventories
22699
Annuals > 2 > balance Sheet > total Current Assets
257933
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
1676112
Annuals > 2 > balance Sheet > payables
12297
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
31584
Annuals > 2 > balance Sheet > equity
1642792
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-517656
Annuals > 2 > cash Flow > depreciation
19956
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-137464
Annuals > 2 > cash Flow > capital Expenditures
4699
Annuals > 2 > cash Flow > cash From Investing
-775000
Annuals > 2 > cash Flow > cash From Financing
1125101
Annuals > 2 > cash Flow > net Change In Cash
212637
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.03394999868831816
Annuals > 2 > ratios > PB
0.000928151585836795
Annuals > 2 > ratios > ROE
-31.51074512171961
Annuals > 2 > ratios > ROA
-30.884332311921874
Annuals > 2 > ratios > FCF
-142163
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.120757781973043
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2016-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
98112
Annuals > 3 > income Statement > operating Income
-98112
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-98112
Annuals > 3 > income Statement > net Income
-98112
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
0
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
0
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
0
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
0
Annuals > 3 > balance Sheet > payables
2260
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
8176
Annuals > 3 > balance Sheet > equity
-8176
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-98112
Annuals > 3 > cash Flow > depreciation
19956
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-70992
Annuals > 3 > cash Flow > capital Expenditures
4699
Annuals > 3 > cash Flow > cash From Investing
-775000
Annuals > 3 > cash Flow > cash From Financing
70992
Annuals > 3 > cash Flow > net Change In Cash
212637
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
0
Annuals > 3 > ratios > ROE
1200
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-75691
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.0959785988978336
Valuation > metrics > PB
0.0061503175267804185
Valuation > final Score
70
Valuation > verdict
99.4% Undervalued
Profitability > metrics > ROE
-590.2988589971737
Profitability > metrics > ROA
-633.4345850163111
Profitability > metrics > Net Margin
-7.981070322865989
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
9.946229805645697
Risk > metrics > Interest Coverage
-10.899502342249233
Risk > final Score
-38
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.1746363360690375
Liquidity > metrics > Quick Ratio
0.09165467190757946
Liquidity > final Score
15
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-55
Prev Risks > 1
-14
Prev Risks > 2
38
Prev Liquidities > 0
20
Prev Liquidities > 1
35
Prev Liquidities > 2
81
Updated At
2026-01-20T21:24:04.588Z
Earnings History > 0 > period
2019-12-31
Earnings History > 0 > report Date
2020-02-18
Earnings History > 0 > date
2019-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.1
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2019-09-30
Earnings History > 1 > report Date
2019-11-14
Earnings History > 1 > date
2019-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.06
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2019-06-30
Earnings History > 2 > report Date
2019-07-01
Earnings History > 2 > date
2019-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.02
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2019-03-31
Earnings History > 3 > report Date
2019-06-30
Earnings History > 3 > date
2019-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0307
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2018-12-31
Earnings History > 4 > report Date
2019-02-13
Earnings History > 4 > date
2018-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.16
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2018-09-30
Earnings History > 5 > report Date
2018-11-14
Earnings History > 5 > date
2018-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2018-06-30
Earnings History > 6 > report Date
2018-08-14
Earnings History > 6 > date
2018-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.04
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2018-03-31
Earnings History > 7 > report Date
2018-06-28
Earnings History > 7 > date
2018-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.12
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2017-12-31
Earnings History > 8 > report Date
2018-02-14
Earnings History > 8 > date
2017-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.02
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2017-09-30
Earnings History > 9 > report Date
2017-12-31
Earnings History > 9 > date
2017-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0215
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2017-06-30
Earnings History > 10 > report Date
2017-09-30
Earnings History > 10 > date
2017-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0116
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2017-03-31
Earnings History > 11 > report Date
2017-06-30
Earnings History > 11 > date
2017-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0129
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2016-12-31
Earnings History > 12 > report Date
2017-03-31
Earnings History > 12 > date
2016-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.005
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2016-09-30
Earnings History > 13 > report Date
2016-12-31
Earnings History > 13 > date
2016-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0311
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-06-30
Earnings History > 14 > report Date
2016-09-30
Earnings History > 14 > date
2016-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0031
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-03-31
Earnings History > 15 > report Date
2016-06-30
Earnings History > 15 > date
2016-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0015
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2019-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Applied Biosciences Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2019-12-31
EPS Actual
-0.1
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2019-12-31)
(Last Updated 2019-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2019-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2019-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.